Preeclampsia and ABO blood groups: a systematic review and meta-analysis

被引:0
作者
Patricia Nessralla Alpoim
Melina de Barros Pinheiro
Daniela Rezende Garcia Junqueira
Leticia Gonçalves Freitas
Maria das Graças Carvalho
Ana Paula Salles Moura Fernandes
Flávia Komatsuzaki
Karina Braga Gomes
Luci Maria Sant’Ana Dusse
机构
[1] Federal University of Minas Gerais,Department of Clinical and Toxicological Analyses, School of Pharmacy
[2] Federal University of Minas Gerais,Centre of Drug Studies (Cemed), Department of Social Pharmacy, School of Pharmacy
来源
Molecular Biology Reports | 2013年 / 40卷
关键词
Preeclampsia; ABO blood-group system; Risk factors; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
Preeclampsia (PE) is a multifactorial pregnancy-specific syndrome which represents one of the leading causes of maternal mortality worldwide. Inherited thrombophilia have been investigated as risk factor for the development of PE and it is currently known that ABO blood group may impact haemostatic balance, having the non-O blood groups (A, B or AB) subjects increased risk for thrombus formation, as compared to those of group O. We performed a systematic review of the literature for published studies investigating whether ABO blood groups could influence PE developing. A sensitive search of four databases identified 45 unique titles. The retrieved papers were assessed independently by authors and a rigorous process of selection and data extract was conduct. Methodological quality of the included studies was also evaluated. Two studies met eligibility criteria. As a main finding of our systematic review, an association between the AB blood group and the occurrence of PE was detected based on two original studies. Considering the role of ABO blood groups on the hemostatic process and thrombus formation, special attention should be given to pregnant patients carrying the AB blood group in order to prevent the syndrome and improve prognosis.
引用
收藏
页码:2253 / 2261
页数:8
相关论文
共 234 条
[1]  
Young BC(2010)Pathogenesis of preeclampsia Annu Rev Pathol 5 173-192
[2]  
Levine RJ(2002)American College of Obstetricians and Gynecologists Int J Gynaecol Obstet 77 67-75
[3]  
Karumanchi SA(1998)Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies Am J Obstet Gynecol 179 520-526
[4]  
Higgins JR(2000)Fetal distress Baillieres Best Pract Res Clin Obstet Gynaecol 14 155-172
[5]  
Walshe JJ(2005)Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies Br Med J 330 565-273
[6]  
Darling MR(2002)Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome J Matern Fetal Neonatal 12 267-49
[7]  
Norris L(2000)Severe preeclampsia and high frequency of genetic thrombophilic mutations Obstet Gynecol 96 45-980
[8]  
Bonnar J(1999)Preeclampsia and genetic risk factors for thrombosis: a case-control study Am J Obstet Gynecol 181 975-1920
[9]  
Tharmaratnam S(2003)The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome J Hypertens 21 1915-22
[10]  
Duckitt K(2003)Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia Gynecol Obstet Invest 56 17-1593